Herbas VPB

Print
EN | LT
LT - Pegiliuoti rekombinantinio žmogaus augimo hormono junginiai
EN - PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/27 (2006.01)
A61K 47/65 (2017.01)
A61K 47/60 (2017.01)
A61P 11/00 (2006.01)
A61P 13/12 (2006.01)
A61P 43/00 (2006.01)
A61P 1/04 (2006.01)
A61P 1/16 (2006.01)
A61P 3/04 (2006.01)
A61P 15/08 (2006.01)
A61P 19/02 (2006.01)
A61P 21/00 (2006.01)
A61P 25/24 (2006.01)
A61P 29/00 (2006.01)
A61P 31/18 (2006.01)
A61P 35/00 (2006.01)
A61P 37/06 (2006.01)
A61P 39/06 (2006.01)
A61P 5/06 (2006.01)
A61P 9/00 (2006.01)
European patent
(11) Number of the document 3050576
(13) Kind of document T
(96) European patent application number 16156852.2
Date of filing the European patent application 2009-04-29
(97) Date of publication of the European application 2016-08-03
(45) Date of publication and mention of the grant of the patent 2021-03-31
(46) Date of publication of the claims translation 2021-07-12
Priority applications
(30) Number Date Country code
08155408 2008-04-29 EP
08162865 2008-08-22 EP
08167289 2008-10-22 EP
Inventors
(72)
Rau, Harald, DE
Kindermann, Susanne, DE
Lessmann, Torben, DE
Rasmussen, Grethe N rskov, DK
Hersel, Ulrich, DE
Wegge, Thomas, DE
Sprog e, Kennett, DK
Grantee
(73) ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S, Tuborg Boulevard 12, 2900 Hellerup, DK
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Pegiliuoti rekombinantinio žmogaus augimo hormono junginiai
  PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS
Last renewal fee
Payment date Validity (years) Amount
2025-04-16 17 347.00 EUR
Next renewal fee
2026-04-29